Program for Aging Research in the Summer (PARIS)

夏季老龄化研究计划(巴黎)

基本信息

  • 批准号:
    10407548
  • 负责人:
  • 金额:
    $ 7.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Worldwide there are about 617 million people aged 65 or older, and this population continues to increase at an unparalleled rate. According to a report from the United States Census Bureau and commissioned by the National Institute on Aging, the current global population of older individuals of 8.5% is expected to surge to approximately 1.6 billion people, or almost 17% of the world's population, by 2050. The 65-and-over population of the United States is predicted to nearly double over the next three decades, from 48 million to 88 million Although it is well known that age is a risk factor for a variety of acute and chronic disorders, the mechanisms underlying aging, and the best way to minimize the effects of this process on health, are not well understood. Therefore, research into the mechanisms of the aging process and treatment of age-related diseases is critical. In addition, as the American population continues to age, there will be a growing need for physicians trained to care for the elderly and diseases related to aging. Finally, there continues to be a gap in the number of under-represented minorities trained as physicians and physician-scientists. The proposed program will address these issues by providing under-represented minority medical students with the opportunity to participate in aging research and to observe geriatricians in the clinic, with the idea of promoting a sustained interest in this field of medicine and research. The Program for Aging Research in the Summer, or PARIS, will build upon the success of a pilot program initiated as part of the Co-Principal Investigator's P01 Project, which for the past three years has arranged transportation, housing and research mentors for three students from the Puerto Rican medical school, Universidad Central del Caribe (UCC), to pursue aging research with one of the members of the Program Project. This program has gradually received positive publicity from the students, such that this past application period the number of applicants to the program far exceeded the number of slots available. Therefore, in the program described in this application we are proposing to increase the number of slots in the program, as well as to extend the opportunity to participate to medical students from other Puerto Rican medical schools, including Ponce Health Sciences University and San Juan Bautista School of Medicine. The goals of this program are to: (I) organize the participation of under-represented minority medical students in aging research at Augusta University, (II) develop didactic training in research methods and statistics for PARIS trainees, (III) organize a clinical observership for PARIS trainees with physicians caring for older individuals and (IV) establish a mechanism to sustain trainees' interest in aging research and track trainee outcomes. With this program we hope to encourage under-represented minority engagement in careers in geroscience and geriatrics.
在全球范围内,大约有65人或65岁以上的人群,以无与伦比的速度继续增加。根据美国人口普查局的一份报告,并由美国国立衰老研究所委托,预计目前的8.5%的年龄较大的全球人口预计将增加到约16亿人口,即2050年的全球人口,或几乎占世界人口的近17%。到2050年。在未来三十年中,美国的65万人人口将在4800万人中估计,这是一个年龄段的销量,即众所周知,这是一定数量的一倍。疾病,衰老的基础机制以及最大程度地减少该过程对健康的影响的最佳方法。因此,研究与年龄相关疾病的衰老过程机制和治疗的研究至关重要。此外,随着美国人口的持续年龄,越来越需要接受培训的医生来照顾与衰老有关的老年人和疾病。最后,在代表性不足的少数群体中,作为医生和医师科学家培训的人数仍然存在差距。拟议的计划将通过为代表性不足的少数族裔医学生提供参与衰老研究并观察诊所中的老年医生的机会来解决这些问题,并以促进对这一医学和研究领域的持续兴趣。夏季或巴黎的衰老研究计划将建立在一项试点计划的成功基础上,该计划是该计划的一部分,该计划是该计划的P01项目的一部分,在过去的三年中,该计划安排了来自波多黎各Rican Medical School的三名学生的运输,住房和研究导师,该计划与一名项目成员进行研究。该计划逐渐从学生那里获得了积极的宣传,因此在过去的申请期间,该计划的申请人数量远远超过了可用的插槽数量。因此,在本申请中描述的计划中,我们提议增加该计划中的老虎机数量,并扩大机会参加来自其他波多黎各医学院的医学生,包括Ponce Health Sciences University和San Juan Bautista医学院。该计划的目标是:(i)组织代表性不足的少数族裔医学生的参与,奥古斯塔大学(II)开发了巴黎学员的研究方法和统计研究中的教学培训,(iii)组织一名临床观察者,为老年人和培训者提供护理人员的临床观察者,以维持培训者的兴趣和培训者的兴趣,并建立了型号的兴趣。通过该计划,我们希望鼓励代表性不足的少数群体从事Geroscience和Geriatrics的职业。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wendy B Bollag其他文献

Association of psoriasis and stroke in end-stage renal disease patients.
终末期肾病患者牛皮癣和中风的关联。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    N. Siddiquee;J. Waller;S. Baer;Azeem A. Mohammed;S. Tran;S. Padala;Lufei Young;M. Kheda;Wendy B Bollag
  • 通讯作者:
    Wendy B Bollag

Wendy B Bollag的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wendy B Bollag', 18)}}的其他基金

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10373069
  • 财政年份:
    2021
  • 资助金额:
    $ 7.96万
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10618156
  • 财政年份:
    2021
  • 资助金额:
    $ 7.96万
  • 项目类别:
The Aquaporin-3/Phospholipase D2 Signaling Pathway in Corneal Wound Healing
角膜伤口愈合中的 Aquaporin-3/磷脂酶 D2 信号通路
  • 批准号:
    10664930
  • 财政年份:
    2020
  • 资助金额:
    $ 7.96万
  • 项目类别:
Program for Aging Research in the Summer (PARIS)
夏季老龄化研究计划(巴黎)
  • 批准号:
    9982017
  • 财政年份:
    2020
  • 资助金额:
    $ 7.96万
  • 项目类别:
Program for Aging Research in the Summer (PARIS)
夏季老龄化研究计划(巴黎)
  • 批准号:
    10163771
  • 财政年份:
    2020
  • 资助金额:
    $ 7.96万
  • 项目类别:
The Aquaporin-3/Phospholipase D2 Signaling Pathway in Corneal Wound Healing
角膜伤口愈合中的 Aquaporin-3/磷脂酶 D2 信号通路
  • 批准号:
    10201519
  • 财政年份:
    2020
  • 资助金额:
    $ 7.96万
  • 项目类别:
The Aquaporin-3/Phospholipase D2 Signaling Pathway in Corneal Wound Healing
角膜伤口愈合中的 Aquaporin-3/磷脂酶 D2 信号通路
  • 批准号:
    10016063
  • 财政年份:
    2020
  • 资助金额:
    $ 7.96万
  • 项目类别:
Program for Aging Research in the Summer (PARIS)
夏季老龄化研究计划(巴黎)
  • 批准号:
    10624835
  • 财政年份:
    2020
  • 资助金额:
    $ 7.96万
  • 项目类别:
Phosphatidylglycerol as a Therapy for Corneal Injury
磷脂酰甘油治疗角膜损伤
  • 批准号:
    10179401
  • 财政年份:
    2019
  • 资助金额:
    $ 7.96万
  • 项目类别:
ShEEP Request for Laser Scanning Microscope (LSM) 880
ShEEP 请求激光扫描显微镜 (LSM) 880
  • 批准号:
    9907067
  • 财政年份:
    2019
  • 资助金额:
    $ 7.96万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mucosal immunity to sapovirus in early childhood
幼儿期对沙波病毒的粘膜免疫
  • 批准号:
    10677051
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
  • 批准号:
    10678789
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
Measuring Social Isolation, Loneliness, and Intersectional Stigma among Older Adults with Opioid Use Disorder
衡量患有阿片类药物使用障碍的老年人的社会孤立、孤独和交叉耻辱
  • 批准号:
    10683023
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome Cargo
TBI 和认知能力下降对阿尔茨海默病脑源性外泌体货物的影响
  • 批准号:
    10662883
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
  • 批准号:
    10651082
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了